- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03207594
Improving Evidence-Based Care for Cancer Patients
January 29, 2025 updated by: Medical University of South Carolina
The purpose of this study is to improve cancer care and the delivery of cancer care.
Researchers are interested in studying patient reported information and examining how different factors may impact cancer care.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
128
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patient who have been diagnosed with head/neck, lung, breast, prostate, gastrointestinal or gynecologic cancers that are 21 years of age or older.
Patients must have been referred to MUSC radiation oncology for treatment with curative radiation therapy
Description
Inclusion Criteria:
- Diagnosed with head/neck, lung, breast, prostate, gastrointestinal or gynecologic cancer
- 21 years of age or older at time of study registration
- Must have been referred to MUSC radiation oncology for treatment with curative radiation therapy
- Must report current smoking defined as self-reporting smoking within the past 30 days using a structured intake questionnaire.
Exclusion Criteria:
- Patients with primary central nervous system malignancies will be excluded.
- Patients that have other cancer disease types will be excluded due to either significant differences in standard radiation therapy approaches or rarity of disease required radiation.
- Patients who are currently participating in the Medical University of South Carolina Hollings Cancer Center smoking cessation program
- Patients who are unable to provide informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Arm 1
Current smokers with cancer who are planning to get radiation therapy at MUSC.
|
Subjects will be asked to complete a survey asking questions about his/her current health, well-being and quality of life.
Subjects will have saliva collected by a member of the study team using a cotton swab.
Subjects will be asked to complete an assessment asking questions about his/her current smoking status
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patients with biochemically confirmed smoking cessation
Time Frame: 4 weeks after enrollment
|
Biochemical confirmation will be determined by saliva samples
|
4 weeks after enrollment
|
|
Number of patient who self-report smoking cessation
Time Frame: 4 weeks after enrollment
|
Self-reported smoking cessation will be documented via smoking assessment questionnaire
|
4 weeks after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Average weekly smoke exposure
Time Frame: up to 62 weeks
|
reported cigarettes per day multiplied by the number of days smoked during radiation therapy (RT), summed over a period of time and normalized to yield an average weekly smoke exposure during RT.
|
up to 62 weeks
|
|
Number of patients who participate in smoking cessation
Time Frame: up to 12 months after completion of RT.
|
Completing one in-person visit where an individualized smoking cessation treatment plan is developed and implemented.
|
up to 12 months after completion of RT.
|
|
Compliance with smoking cessation
Time Frame: up to 12 weeks after completion of RT
|
Two binary measure of compliance:
|
up to 12 weeks after completion of RT
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Graham Warren, MD, PhD, Medical University of South Carolina
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2016
Primary Completion (Actual)
May 1, 2019
Study Completion (Actual)
March 1, 2020
Study Registration Dates
First Submitted
March 22, 2017
First Submitted That Met QC Criteria
June 30, 2017
First Posted (Actual)
July 5, 2017
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 29, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 102472
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.